Form 8-K - Current report:
SEC Accession No. 0001104659-19-060131
Filing Date
2019-11-05
Accepted
2019-11-05 17:27:01
Documents
14
Period of Report
2019-11-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1921677d1_8k.htm   iXBRL 8-K 23380
2 EXHIBIT 99.1 tm1921677d1_ex99-1.htm EX-99.1 9365
6 GRAPHIC tm1921677d1_img001.jpg GRAPHIC 7922
  Complete submission text file 0001104659-19-060131.txt   219479

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qure-20191105.xsd EX-101.SCH 3183
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qure-20191105_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qure-20191105_pre.xml EX-101.PRE 22708
10 EXTRACTED XBRL INSTANCE DOCUMENT tm1921677d1_8k_htm.xml XML 3498
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 191194393
SIC: 2834 Pharmaceutical Preparations